174 related articles for article (PubMed ID: 35729665)
1. Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study.
Legoupil S; Bessis D; Picard F; Mallet S; Mazereeuw J; Phan A; Dupin-Deguine D; Kalamarides M; ; Chiaverini C
Orphanet J Rare Dis; 2022 Jun; 17(1):242. PubMed ID: 35729665
[TBL] [Abstract][Full Text] [Related]
2. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
3. [Neurofibromatosis type 2 in the otorhinolaryngological practice].
Subbotina MV; Berseneva AV
Vestn Otorinolaringol; 2024; 89(1):37-41. PubMed ID: 38506024
[TBL] [Abstract][Full Text] [Related]
4. [Neurofibromatosis 1].
Yoshida Y
Brain Nerve; 2019 Apr; 71(4):368-372. PubMed ID: 30988223
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis 2 in the pediatric age group.
Mautner VF; Tatagiba M; Guthoff R; Samii M; Pulst SM
Neurosurgery; 1993 Jul; 33(1):92-6. PubMed ID: 8355853
[TBL] [Abstract][Full Text] [Related]
6. Paediatric presentation of type 2 neurofibromatosis.
Evans DG; Birch JM; Ramsden RT
Arch Dis Child; 1999 Dec; 81(6):496-9. PubMed ID: 10569966
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic Relevance of the Cutaneous Manifestations of Neurofibromatosis Type 2.
Plana-Pla A; Bielsa-Marsol I; Carrato-Moñino C;
Actas Dermosifiliogr; 2017 Sep; 108(7):630-636. PubMed ID: 28237041
[TBL] [Abstract][Full Text] [Related]
8. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
Bernier A; Larbrisseau A; Perreault S
Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Café-au-lait Macules and their Association with the Neurofibromatosis type I Genotype in a Cohort of Greek Children.
Nasi L; Alexopoulos A; Kokkinou E; Roka K; Tzetis M; Tsipi M; Kakourou T; Kanaka-Gantenbein C; Chrousos G; Kattamis A; Pons R;
Acta Derm Venereol; 2023 Jun; 103():adv5758. PubMed ID: 37272364
[TBL] [Abstract][Full Text] [Related]
10. [Neurofibromatosis].
Wolkenstein P; Decq P
Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
[TBL] [Abstract][Full Text] [Related]
11. Infantile onset neurofibromatosis type 2 presenting with peripheral facial palsy, skin patches, retinal hamartoma and foot drop.
Tibussek D; Hübsch S; Berger K; Schaper J; Rosenbaum T; Mayatepek E
Klin Padiatr; 2009; 221(4):247-50. PubMed ID: 19629903
[TBL] [Abstract][Full Text] [Related]
12. Astrocytic hamartoma of the optic disc and multiple café-au-lait macules in a child with neurofibromatosis type 2.
Sachdeva R; Rothner DA; Traboulsi EI; Hayden BC; Rychwalski PJ
Ophthalmic Genet; 2010 Dec; 31(4):209-14. PubMed ID: 21067482
[TBL] [Abstract][Full Text] [Related]
13. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population.
Anand G; Vasallo G; Spanou M; Thomas S; Pike M; Kariyawasam DS; Mehta S; Parry A; Durie-Gair J; Nicholson J; Lascelles K; Everett V; Gibbon FM; Jarvis N; Elston J; Evans DG; Halliday D
Arch Dis Child; 2018 May; 103(5):463-469. PubMed ID: 29535107
[TBL] [Abstract][Full Text] [Related]
15. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.
Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Di Mauro P; Licciardello L; Milone P; Privitera G; Belfiore G; Di Pietro M; Di Raimondo F; Romano A; Chiarenza A; Muglia M; Polizzi A; Evans DG
Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):345-367. PubMed ID: 27958595
[TBL] [Abstract][Full Text] [Related]
16. Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas.
Plana-Pla A; García B; Munera-Campos M; Catasus N; Serra Arenas E; Blanco I; Castellanos Perez E; Bielsa I;
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1632-1640. PubMed ID: 35490384
[TBL] [Abstract][Full Text] [Related]
17. Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.
Stewart DR; Brems H; Gomes AG; Ruppert SL; Callens T; Williams J; Claes K; Bober MB; Hachen R; Kaban LB; Li H; Lin A; McDonald M; Melancon S; Ortenberg J; Radtke HB; Samson I; Saul RA; Shen J; Siqveland E; Toler TL; van Maarle M; Wallace M; Williams M; Legius E; Messiaen L
Genet Med; 2014 Jun; 16(6):448-59. PubMed ID: 24232412
[TBL] [Abstract][Full Text] [Related]
18. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
19. Multiple café au lait spots in familial patients with MAP2K2 mutation.
Takenouchi T; Shimizu A; Torii C; Kosaki R; Takahashi T; Saya H; Kosaki K
Am J Med Genet A; 2014 Feb; 164A(2):392-6. PubMed ID: 24311457
[TBL] [Abstract][Full Text] [Related]
20. An update on the CNS manifestations of neurofibromatosis type 2.
Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]